nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—SRC—Vandetanib—thyroid cancer	0.633	0.844	CbGbCtD
Trabectedin—CYP2C19—Sorafenib—thyroid cancer	0.0253	0.0337	CbGbCtD
Trabectedin—CYP2C9—Sorafenib—thyroid cancer	0.021	0.028	CbGbCtD
Trabectedin—CYP3A4—Vandetanib—thyroid cancer	0.0203	0.0271	CbGbCtD
Trabectedin—CYP2D6—Sorafenib—thyroid cancer	0.0192	0.0256	CbGbCtD
Trabectedin—CYP3A4—Sorafenib—thyroid cancer	0.0122	0.0163	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—thyroid cancer	0.0117	0.0156	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—thyroid cancer	0.00742	0.00989	CbGbCtD
Trabectedin—Haemoglobin—Vandetanib—thyroid cancer	0.00105	0.0065	CcSEcCtD
Trabectedin—Haemorrhage—Vandetanib—thyroid cancer	0.00105	0.00647	CcSEcCtD
Trabectedin—Angiopathy—Vandetanib—thyroid cancer	0.000952	0.00587	CcSEcCtD
Trabectedin—Dehydration—Sorafenib—thyroid cancer	0.000951	0.00587	CcSEcCtD
Trabectedin—Mediastinal disorder—Vandetanib—thyroid cancer	0.000945	0.00583	CcSEcCtD
Trabectedin—Mucosal inflammation—Epirubicin—thyroid cancer	0.000941	0.0058	CcSEcCtD
Trabectedin—Abdominal pain upper—Sorafenib—thyroid cancer	0.000934	0.00576	CcSEcCtD
Trabectedin—Hypokalaemia—Sorafenib—thyroid cancer	0.000931	0.00574	CcSEcCtD
Trabectedin—Alopecia—Vandetanib—thyroid cancer	0.000927	0.00572	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.000921	0.00568	CcSEcCtD
Trabectedin—Mental disorder—Vandetanib—thyroid cancer	0.000919	0.00567	CcSEcCtD
Trabectedin—Malnutrition—Vandetanib—thyroid cancer	0.000913	0.00563	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.000902	0.00556	CcSEcCtD
Trabectedin—Dysgeusia—Vandetanib—thyroid cancer	0.000894	0.00552	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.000876	0.0054	CcSEcCtD
Trabectedin—Mucosal inflammation—Doxorubicin—thyroid cancer	0.00087	0.00537	CcSEcCtD
Trabectedin—Febrile neutropenia—Epirubicin—thyroid cancer	0.000866	0.00534	CcSEcCtD
Trabectedin—Neutropenia—Sorafenib—thyroid cancer	0.000827	0.0051	CcSEcCtD
Trabectedin—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.00081	0.005	CcSEcCtD
Trabectedin—Loss of consciousness—Vandetanib—thyroid cancer	0.000803	0.00495	CcSEcCtD
Trabectedin—Febrile neutropenia—Doxorubicin—thyroid cancer	0.000801	0.00494	CcSEcCtD
Trabectedin—Weight decreased—Sorafenib—thyroid cancer	0.0008	0.00493	CcSEcCtD
Trabectedin—Cough—Vandetanib—thyroid cancer	0.000797	0.00492	CcSEcCtD
Trabectedin—Infestation NOS—Sorafenib—thyroid cancer	0.000788	0.00486	CcSEcCtD
Trabectedin—Infestation—Sorafenib—thyroid cancer	0.000788	0.00486	CcSEcCtD
Trabectedin—Arthralgia—Vandetanib—thyroid cancer	0.000777	0.0048	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000772	0.00476	CcSEcCtD
Trabectedin—Jaundice—Sorafenib—thyroid cancer	0.000768	0.00474	CcSEcCtD
Trabectedin—Stomatitis—Sorafenib—thyroid cancer	0.000768	0.00474	CcSEcCtD
Trabectedin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000745	0.0046	CcSEcCtD
Trabectedin—Oedema—Vandetanib—thyroid cancer	0.000745	0.0046	CcSEcCtD
Trabectedin—Infection—Vandetanib—thyroid cancer	0.00074	0.00457	CcSEcCtD
Trabectedin—Hepatomegaly—Epirubicin—thyroid cancer	0.000736	0.00454	CcSEcCtD
Trabectedin—Nervous system disorder—Vandetanib—thyroid cancer	0.000731	0.00451	CcSEcCtD
Trabectedin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00073	0.0045	CcSEcCtD
Trabectedin—Skin disorder—Vandetanib—thyroid cancer	0.000724	0.00447	CcSEcCtD
Trabectedin—Haemoglobin—Sorafenib—thyroid cancer	0.000711	0.00439	CcSEcCtD
Trabectedin—Haemorrhage—Sorafenib—thyroid cancer	0.000708	0.00436	CcSEcCtD
Trabectedin—Connective tissue disorder—Sorafenib—thyroid cancer	0.000695	0.00429	CcSEcCtD
Trabectedin—Hepatomegaly—Doxorubicin—thyroid cancer	0.000681	0.0042	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000679	0.00419	CcSEcCtD
Trabectedin—Insomnia—Vandetanib—thyroid cancer	0.000674	0.00416	CcSEcCtD
Trabectedin—Paraesthesia—Vandetanib—thyroid cancer	0.000669	0.00413	CcSEcCtD
Trabectedin—Dyspnoea—Vandetanib—thyroid cancer	0.000664	0.0041	CcSEcCtD
Trabectedin—Necrosis—Epirubicin—thyroid cancer	0.000663	0.00409	CcSEcCtD
Trabectedin—Flushing—Sorafenib—thyroid cancer	0.000657	0.00405	CcSEcCtD
Trabectedin—Dyspepsia—Vandetanib—thyroid cancer	0.000656	0.00405	CcSEcCtD
Trabectedin—Decreased appetite—Vandetanib—thyroid cancer	0.000648	0.004	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000643	0.00397	CcSEcCtD
Trabectedin—Fatigue—Vandetanib—thyroid cancer	0.000643	0.00396	CcSEcCtD
Trabectedin—Angiopathy—Sorafenib—thyroid cancer	0.000642	0.00396	CcSEcCtD
Trabectedin—Mediastinal disorder—Sorafenib—thyroid cancer	0.000638	0.00393	CcSEcCtD
Trabectedin—Constipation—Vandetanib—thyroid cancer	0.000637	0.00393	CcSEcCtD
Trabectedin—Alopecia—Sorafenib—thyroid cancer	0.000625	0.00386	CcSEcCtD
Trabectedin—Mental disorder—Sorafenib—thyroid cancer	0.00062	0.00382	CcSEcCtD
Trabectedin—Liver injury—Epirubicin—thyroid cancer	0.000619	0.00382	CcSEcCtD
Trabectedin—Malnutrition—Sorafenib—thyroid cancer	0.000616	0.0038	CcSEcCtD
Trabectedin—Necrosis—Doxorubicin—thyroid cancer	0.000614	0.00379	CcSEcCtD
Trabectedin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000609	0.00376	CcSEcCtD
Trabectedin—Dysgeusia—Sorafenib—thyroid cancer	0.000603	0.00372	CcSEcCtD
Trabectedin—Extravasation—Epirubicin—thyroid cancer	0.000597	0.00368	CcSEcCtD
Trabectedin—Abdominal pain—Vandetanib—thyroid cancer	0.000589	0.00363	CcSEcCtD
Trabectedin—Body temperature increased—Vandetanib—thyroid cancer	0.000589	0.00363	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.000573	0.00353	CcSEcCtD
Trabectedin—Liver injury—Doxorubicin—thyroid cancer	0.000573	0.00353	CcSEcCtD
Trabectedin—Anaemia—Sorafenib—thyroid cancer	0.000569	0.00351	CcSEcCtD
Trabectedin—Syncope—Sorafenib—thyroid cancer	0.000552	0.00341	CcSEcCtD
Trabectedin—Extravasation—Doxorubicin—thyroid cancer	0.000552	0.00341	CcSEcCtD
Trabectedin—Leukopenia—Sorafenib—thyroid cancer	0.000551	0.0034	CcSEcCtD
Trabectedin—Loss of consciousness—Sorafenib—thyroid cancer	0.000541	0.00334	CcSEcCtD
Trabectedin—Cough—Sorafenib—thyroid cancer	0.000538	0.00332	CcSEcCtD
Trabectedin—Asthenia—Vandetanib—thyroid cancer	0.000535	0.0033	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00053	0.00327	CcSEcCtD
Trabectedin—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000527	0.00325	CcSEcCtD
Trabectedin—Arthralgia—Sorafenib—thyroid cancer	0.000524	0.00323	CcSEcCtD
Trabectedin—Myalgia—Sorafenib—thyroid cancer	0.000524	0.00323	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000521	0.00321	CcSEcCtD
Trabectedin—Pulmonary embolism—Epirubicin—thyroid cancer	0.000521	0.00321	CcSEcCtD
Trabectedin—Injection site reaction—Epirubicin—thyroid cancer	0.000518	0.00319	CcSEcCtD
Trabectedin—Diarrhoea—Vandetanib—thyroid cancer	0.00051	0.00315	CcSEcCtD
Trabectedin—Infection—Sorafenib—thyroid cancer	0.000499	0.00308	CcSEcCtD
Trabectedin—Shock—Sorafenib—thyroid cancer	0.000495	0.00305	CcSEcCtD
Trabectedin—Nervous system disorder—Sorafenib—thyroid cancer	0.000493	0.00304	CcSEcCtD
Trabectedin—Dizziness—Vandetanib—thyroid cancer	0.000493	0.00304	CcSEcCtD
Trabectedin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000492	0.00304	CcSEcCtD
Trabectedin—Skin disorder—Sorafenib—thyroid cancer	0.000488	0.00301	CcSEcCtD
Trabectedin—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000488	0.00301	CcSEcCtD
Trabectedin—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000482	0.00297	CcSEcCtD
Trabectedin—Anorexia—Sorafenib—thyroid cancer	0.000479	0.00296	CcSEcCtD
Trabectedin—Injection site reaction—Doxorubicin—thyroid cancer	0.000479	0.00295	CcSEcCtD
Trabectedin—Vomiting—Vandetanib—thyroid cancer	0.000474	0.00292	CcSEcCtD
Trabectedin—Rash—Vandetanib—thyroid cancer	0.00047	0.0029	CcSEcCtD
Trabectedin—Dermatitis—Vandetanib—thyroid cancer	0.000469	0.0029	CcSEcCtD
Trabectedin—Headache—Vandetanib—thyroid cancer	0.000467	0.00288	CcSEcCtD
Trabectedin—Pulmonary oedema—Epirubicin—thyroid cancer	0.000464	0.00286	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000458	0.00283	CcSEcCtD
Trabectedin—Sepsis—Epirubicin—thyroid cancer	0.000452	0.00279	CcSEcCtD
Trabectedin—Dyspnoea—Sorafenib—thyroid cancer	0.000448	0.00276	CcSEcCtD
Trabectedin—Nausea—Vandetanib—thyroid cancer	0.000443	0.00273	CcSEcCtD
Trabectedin—Dyspepsia—Sorafenib—thyroid cancer	0.000443	0.00273	CcSEcCtD
Trabectedin—Decreased appetite—Sorafenib—thyroid cancer	0.000437	0.0027	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000435	0.00268	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000434	0.00268	CcSEcCtD
Trabectedin—Fatigue—Sorafenib—thyroid cancer	0.000433	0.00267	CcSEcCtD
Trabectedin—Constipation—Sorafenib—thyroid cancer	0.00043	0.00265	CcSEcCtD
Trabectedin—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000429	0.00265	CcSEcCtD
Trabectedin—Hepatic failure—Epirubicin—thyroid cancer	0.000421	0.00259	CcSEcCtD
Trabectedin—Sepsis—Doxorubicin—thyroid cancer	0.000418	0.00258	CcSEcCtD
Trabectedin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000411	0.00254	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000402	0.00248	CcSEcCtD
Trabectedin—Body temperature increased—Sorafenib—thyroid cancer	0.000397	0.00245	CcSEcCtD
Trabectedin—Abdominal pain—Sorafenib—thyroid cancer	0.000397	0.00245	CcSEcCtD
Trabectedin—Hepatic failure—Doxorubicin—thyroid cancer	0.000389	0.0024	CcSEcCtD
Trabectedin—Hypersensitivity—Sorafenib—thyroid cancer	0.00037	0.00228	CcSEcCtD
Trabectedin—Asthenia—Sorafenib—thyroid cancer	0.000361	0.00222	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000354	0.00218	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—thyroid cancer	0.000352	0.00217	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000345	0.00213	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—thyroid cancer	0.000344	0.00212	CcSEcCtD
Trabectedin—Diarrhoea—Sorafenib—thyroid cancer	0.000344	0.00212	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00034	0.0021	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000333	0.00206	CcSEcCtD
Trabectedin—Dizziness—Sorafenib—thyroid cancer	0.000332	0.00205	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000328	0.00202	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—thyroid cancer	0.000325	0.00201	CcSEcCtD
Trabectedin—Vomiting—Sorafenib—thyroid cancer	0.00032	0.00197	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000319	0.00197	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—thyroid cancer	0.000318	0.00196	CcSEcCtD
Trabectedin—Rash—Sorafenib—thyroid cancer	0.000317	0.00196	CcSEcCtD
Trabectedin—Dermatitis—Sorafenib—thyroid cancer	0.000317	0.00195	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000315	0.00194	CcSEcCtD
Trabectedin—Headache—Sorafenib—thyroid cancer	0.000315	0.00194	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—thyroid cancer	0.00031	0.00191	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000308	0.0019	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—thyroid cancer	0.000306	0.00188	CcSEcCtD
Trabectedin—Nausea—Sorafenib—thyroid cancer	0.000299	0.00184	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—thyroid cancer	0.000296	0.00182	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—thyroid cancer	0.000291	0.0018	CcSEcCtD
Trabectedin—Infestation—Epirubicin—thyroid cancer	0.000291	0.0018	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—thyroid cancer	0.000287	0.00177	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—thyroid cancer	0.000284	0.00175	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—thyroid cancer	0.000284	0.00175	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—thyroid cancer	0.000283	0.00174	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000276	0.0017	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—thyroid cancer	0.000274	0.00169	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—thyroid cancer	0.000272	0.00168	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—thyroid cancer	0.00027	0.00166	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—thyroid cancer	0.00027	0.00166	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—thyroid cancer	0.000263	0.00162	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—thyroid cancer	0.000263	0.00162	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—thyroid cancer	0.000263	0.00162	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—thyroid cancer	0.000262	0.00161	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—thyroid cancer	0.000258	0.00159	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000257	0.00159	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000255	0.00157	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000252	0.00155	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—thyroid cancer	0.000243	0.0015	CcSEcCtD
Trabectedin—Flushing—Epirubicin—thyroid cancer	0.000243	0.0015	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—thyroid cancer	0.000242	0.00149	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000238	0.00147	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000238	0.00147	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—thyroid cancer	0.000237	0.00146	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000236	0.00145	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—thyroid cancer	0.000231	0.00143	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—thyroid cancer	0.000229	0.00141	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—thyroid cancer	0.000228	0.0014	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—thyroid cancer	0.000225	0.00139	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—thyroid cancer	0.000223	0.00138	CcSEcCtD
Trabectedin—Back pain—Epirubicin—thyroid cancer	0.00022	0.00136	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—thyroid cancer	0.00022	0.00135	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000218	0.00135	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—thyroid cancer	0.000214	0.00132	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—thyroid cancer	0.000212	0.00131	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—thyroid cancer	0.000211	0.0013	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—thyroid cancer	0.00021	0.0013	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—thyroid cancer	0.000206	0.00127	CcSEcCtD
Trabectedin—Syncope—Epirubicin—thyroid cancer	0.000204	0.00126	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—thyroid cancer	0.000204	0.00126	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—thyroid cancer	0.000204	0.00126	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—thyroid cancer	0.0002	0.00123	CcSEcCtD
Trabectedin—Cough—Epirubicin—thyroid cancer	0.000199	0.00123	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—thyroid cancer	0.000195	0.0012	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—thyroid cancer	0.000194	0.0012	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—thyroid cancer	0.000194	0.0012	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000192	0.00119	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—thyroid cancer	0.000189	0.00117	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—thyroid cancer	0.000189	0.00116	CcSEcCtD
Trabectedin—Oedema—Epirubicin—thyroid cancer	0.000186	0.00115	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000185	0.00114	CcSEcCtD
Trabectedin—Infection—Epirubicin—thyroid cancer	0.000185	0.00114	CcSEcCtD
Trabectedin—Cough—Doxorubicin—thyroid cancer	0.000184	0.00113	CcSEcCtD
Trabectedin—Shock—Epirubicin—thyroid cancer	0.000183	0.00113	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—thyroid cancer	0.000182	0.00112	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000182	0.00112	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—thyroid cancer	0.00018	0.00111	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—thyroid cancer	0.000179	0.00111	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—thyroid cancer	0.000179	0.00111	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000178	0.0011	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—thyroid cancer	0.000177	0.00109	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—thyroid cancer	0.000174	0.00107	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—thyroid cancer	0.000172	0.00106	CcSEcCtD
Trabectedin—Infection—Doxorubicin—thyroid cancer	0.000171	0.00105	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000169	0.00104	CcSEcCtD
Trabectedin—Shock—Doxorubicin—thyroid cancer	0.000169	0.00104	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000169	0.00104	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000168	0.00104	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—thyroid cancer	0.000168	0.00104	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—thyroid cancer	0.000167	0.00103	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—thyroid cancer	0.000167	0.00103	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—thyroid cancer	0.000166	0.00102	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—thyroid cancer	0.000164	0.00101	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—thyroid cancer	0.000164	0.00101	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—thyroid cancer	0.000162	0.000996	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—thyroid cancer	0.000161	0.000991	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00016	0.000989	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—thyroid cancer	0.00016	0.000988	CcSEcCtD
Trabectedin—Constipation—Epirubicin—thyroid cancer	0.000159	0.00098	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000157	0.000966	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—thyroid cancer	0.000155	0.000959	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—thyroid cancer	0.000154	0.000952	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—thyroid cancer	0.000153	0.000945	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000152	0.000937	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—thyroid cancer	0.000151	0.000933	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—thyroid cancer	0.000149	0.000922	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000148	0.000916	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—thyroid cancer	0.000148	0.000914	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—thyroid cancer	0.000147	0.000907	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—thyroid cancer	0.000147	0.000906	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—thyroid cancer	0.000147	0.000906	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000141	0.000867	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—thyroid cancer	0.000137	0.000844	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—thyroid cancer	0.000136	0.000838	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—thyroid cancer	0.000136	0.000838	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—thyroid cancer	0.000133	0.000822	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—thyroid cancer	0.000127	0.000784	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000127	0.000781	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—thyroid cancer	0.000123	0.000761	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—thyroid cancer	0.000123	0.000758	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—thyroid cancer	0.000118	0.000729	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—thyroid cancer	0.000118	0.000726	CcSEcCtD
Trabectedin—Rash—Epirubicin—thyroid cancer	0.000117	0.000723	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—thyroid cancer	0.000117	0.000722	CcSEcCtD
Trabectedin—Headache—Epirubicin—thyroid cancer	0.000116	0.000718	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—thyroid cancer	0.000114	0.000701	CcSEcCtD
Trabectedin—Nausea—Epirubicin—thyroid cancer	0.00011	0.000681	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—thyroid cancer	0.000109	0.000674	CcSEcCtD
Trabectedin—Rash—Doxorubicin—thyroid cancer	0.000108	0.000669	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—thyroid cancer	0.000108	0.000668	CcSEcCtD
Trabectedin—Headache—Doxorubicin—thyroid cancer	0.000108	0.000664	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—thyroid cancer	0.000102	0.00063	CcSEcCtD
Trabectedin—SRC—Signaling Pathways—CALCB—thyroid cancer	7.81e-05	0.000892	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NDUFA13—thyroid cancer	7.81e-05	0.000891	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	7.74e-05	0.000883	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—AKT1—thyroid cancer	7.72e-05	0.00088	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TRIM33—thyroid cancer	7.41e-05	0.000845	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CDK1—thyroid cancer	7.37e-05	0.000841	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CHST14—thyroid cancer	7.34e-05	0.000838	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—thyroid cancer	7.33e-05	0.000836	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—KRAS—thyroid cancer	7.3e-05	0.000833	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—HRAS—thyroid cancer	7.29e-05	0.000832	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	7.27e-05	0.000829	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—PTEN—thyroid cancer	7.27e-05	0.000829	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—PTEN—thyroid cancer	7.23e-05	0.000825	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	7.23e-05	0.000825	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—NRAS—thyroid cancer	7.21e-05	0.000823	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—PTEN—thyroid cancer	7.2e-05	0.000821	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—AKT1—thyroid cancer	7.18e-05	0.00082	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MINPP1—thyroid cancer	7.09e-05	0.000809	CbGpPWpGaD
Trabectedin—SRC—Disease—TCF7L1—thyroid cancer	7.06e-05	0.000805	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—AKT1—thyroid cancer	7.05e-05	0.000804	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	7e-05	0.000799	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—thyroid cancer	6.98e-05	0.000797	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IFNA2—thyroid cancer	6.95e-05	0.000794	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—HRAS—thyroid cancer	6.94e-05	0.000792	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—RXRA—thyroid cancer	6.84e-05	0.000781	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—KRAS—thyroid cancer	6.83e-05	0.00078	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—PTEN—thyroid cancer	6.74e-05	0.000769	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—AKT1—thyroid cancer	6.73e-05	0.000768	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—HRAS—thyroid cancer	6.68e-05	0.000762	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—HRAS—thyroid cancer	6.68e-05	0.000762	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—PTEN—thyroid cancer	6.68e-05	0.000762	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—PTEN—thyroid cancer	6.62e-05	0.000755	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CCND1—thyroid cancer	6.59e-05	0.000752	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—PTEN—thyroid cancer	6.59e-05	0.000752	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	6.58e-05	0.00075	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	6.57e-05	0.000749	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MINPP1—thyroid cancer	6.52e-05	0.000744	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—BRAF—thyroid cancer	6.51e-05	0.000743	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDK1—thyroid cancer	6.51e-05	0.000743	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—NRAS—thyroid cancer	6.48e-05	0.00074	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MINPP1—thyroid cancer	6.46e-05	0.000737	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—NRAS—thyroid cancer	6.45e-05	0.000736	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.42e-05	0.000733	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—NRAS—thyroid cancer	6.42e-05	0.000733	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—PTEN—thyroid cancer	6.37e-05	0.000726	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	6.34e-05	0.000723	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IFNA2—thyroid cancer	6.26e-05	0.000714	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—HRAS—thyroid cancer	6.21e-05	0.000708	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—KRAS—thyroid cancer	6.2e-05	0.000708	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—AKT1—thyroid cancer	6.13e-05	0.000699	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—AKT1—thyroid cancer	6.03e-05	0.000688	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NDUFA13—thyroid cancer	6.03e-05	0.000688	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—NRAS—thyroid cancer	6.01e-05	0.000686	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—PTEN—thyroid cancer	5.97e-05	0.000681	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—NRAS—thyroid cancer	5.96e-05	0.00068	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HPGD—thyroid cancer	5.92e-05	0.000675	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—NRAS—thyroid cancer	5.9e-05	0.000674	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—AKT1—thyroid cancer	5.9e-05	0.000673	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—NRAS—thyroid cancer	5.88e-05	0.000671	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—thyroid cancer	5.81e-05	0.000663	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—thyroid cancer	5.81e-05	0.000663	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	5.81e-05	0.000663	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.8e-05	0.000662	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CHST14—thyroid cancer	5.66e-05	0.000646	CbGpPWpGaD
Trabectedin—SRC—Immune System—TPR—thyroid cancer	5.6e-05	0.000638	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—KRAS—thyroid cancer	5.58e-05	0.000637	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	5.55e-05	0.000634	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—KRAS—thyroid cancer	5.55e-05	0.000634	CbGpPWpGaD
Trabectedin—SRC—Immune System—LGALS3—thyroid cancer	5.55e-05	0.000633	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NDUFA13—thyroid cancer	5.54e-05	0.000632	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—KRAS—thyroid cancer	5.53e-05	0.00063	CbGpPWpGaD
Trabectedin—SRC—Immune System—PRKAR1A—thyroid cancer	5.5e-05	0.000628	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	5.49e-05	0.000627	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—AKT1—thyroid cancer	5.48e-05	0.000625	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	5.32e-05	0.000607	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—thyroid cancer	5.27e-05	0.000602	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRG1—thyroid cancer	5.23e-05	0.000596	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CHST14—thyroid cancer	5.21e-05	0.000595	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—thyroid cancer	5.19e-05	0.000592	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—KRAS—thyroid cancer	5.17e-05	0.00059	CbGpPWpGaD
Trabectedin—SRC—Disease—TPR—thyroid cancer	5.17e-05	0.00059	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CHST14—thyroid cancer	5.17e-05	0.000589	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—KRAS—thyroid cancer	5.13e-05	0.000585	CbGpPWpGaD
Trabectedin—SRC—Disease—PRKAR1A—thyroid cancer	5.08e-05	0.00058	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—KRAS—thyroid cancer	5.08e-05	0.00058	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—KRAS—thyroid cancer	5.06e-05	0.000577	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRG1—thyroid cancer	5.02e-05	0.000573	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TCF7L1—thyroid cancer	4.94e-05	0.000564	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—AKT1—thyroid cancer	4.91e-05	0.00056	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.87e-05	0.000555	CbGpPWpGaD
Trabectedin—SRC—Disease—MEN1—thyroid cancer	4.86e-05	0.000554	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—thyroid cancer	4.74e-05	0.000541	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—thyroid cancer	4.72e-05	0.000539	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	4.72e-05	0.000539	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—thyroid cancer	4.7e-05	0.000536	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—AKT1—thyroid cancer	4.66e-05	0.000531	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PTEN—thyroid cancer	4.59e-05	0.000524	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	4.58e-05	0.000523	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—AKT1—thyroid cancer	4.58e-05	0.000522	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HPGD—thyroid cancer	4.57e-05	0.000521	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TPR—thyroid cancer	4.55e-05	0.000519	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PRKAR1A—thyroid cancer	4.48e-05	0.000511	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—thyroid cancer	4.4e-05	0.000502	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—thyroid cancer	4.36e-05	0.000497	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.33e-05	0.000494	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PPARG—thyroid cancer	4.32e-05	0.000493	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—thyroid cancer	4.32e-05	0.000493	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—thyroid cancer	4.3e-05	0.000491	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.26e-05	0.000486	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HPGD—thyroid cancer	4.2e-05	0.000479	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—AKT1—thyroid cancer	4.19e-05	0.000478	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—AKT1—thyroid cancer	4.17e-05	0.000476	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	4.17e-05	0.000476	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HPGD—thyroid cancer	4.16e-05	0.000475	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—thyroid cancer	4.15e-05	0.000474	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—AKT1—thyroid cancer	4.15e-05	0.000473	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NRAS—thyroid cancer	4.09e-05	0.000467	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.06e-05	0.000463	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	3.89e-05	0.000444	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—AKT1—thyroid cancer	3.88e-05	0.000443	CbGpPWpGaD
Trabectedin—SRC—Disease—CALCA—thyroid cancer	3.87e-05	0.000441	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—AKT1—thyroid cancer	3.85e-05	0.000439	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—AKT1—thyroid cancer	3.81e-05	0.000435	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—AKT1—thyroid cancer	3.8e-05	0.000433	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDK1—thyroid cancer	3.79e-05	0.000433	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—NRAS—thyroid cancer	3.71e-05	0.000423	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.7e-05	0.000423	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—AKT1—thyroid cancer	3.67e-05	0.000419	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—AKT1—thyroid cancer	3.67e-05	0.000419	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.65e-05	0.000417	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNA2—thyroid cancer	3.65e-05	0.000416	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.62e-05	0.000413	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSHR—thyroid cancer	3.62e-05	0.000413	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PRKAR1A—thyroid cancer	3.56e-05	0.000406	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—KRAS—thyroid cancer	3.52e-05	0.000402	CbGpPWpGaD
Trabectedin—SRC—Disease—CDK1—thyroid cancer	3.5e-05	0.000399	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	3.44e-05	0.000392	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CHST14—thyroid cancer	3.41e-05	0.000389	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.41e-05	0.000389	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MEN1—thyroid cancer	3.4e-05	0.000388	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TPR—thyroid cancer	3.4e-05	0.000388	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.38e-05	0.000385	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	3.34e-05	0.000382	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.25e-05	0.000371	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.19e-05	0.000364	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—thyroid cancer	3.19e-05	0.000364	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTCH1—thyroid cancer	3.08e-05	0.000351	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRG1—thyroid cancer	3.04e-05	0.000347	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—thyroid cancer	3e-05	0.000342	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—RXRA—thyroid cancer	2.86e-05	0.000326	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SST—thyroid cancer	2.81e-05	0.000321	CbGpPWpGaD
Trabectedin—SRC—Disease—NRG1—thyroid cancer	2.81e-05	0.000321	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.78e-05	0.000318	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HPGD—thyroid cancer	2.75e-05	0.000313	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—thyroid cancer	2.71e-05	0.000309	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CALCA—thyroid cancer	2.71e-05	0.000309	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—thyroid cancer	2.64e-05	0.000302	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—thyroid cancer	2.64e-05	0.000302	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TPR—thyroid cancer	2.62e-05	0.000299	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTEN—thyroid cancer	2.62e-05	0.000299	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—thyroid cancer	2.59e-05	0.000296	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.58e-05	0.000294	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC5A5—thyroid cancer	2.54e-05	0.00029	CbGpPWpGaD
Trabectedin—SRC—Disease—TERT—thyroid cancer	2.52e-05	0.000288	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTEN—thyroid cancer	2.51e-05	0.000287	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDK1—thyroid cancer	2.45e-05	0.00028	CbGpPWpGaD
Trabectedin—SRC—Disease—HIF1A—thyroid cancer	2.41e-05	0.000275	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TPR—thyroid cancer	2.41e-05	0.000275	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TPR—thyroid cancer	2.39e-05	0.000273	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.37e-05	0.000271	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.35e-05	0.000268	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.34e-05	0.000267	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—thyroid cancer	2.34e-05	0.000266	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—thyroid cancer	2.28e-05	0.00026	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—thyroid cancer	2.24e-05	0.000256	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—thyroid cancer	2.23e-05	0.000255	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—RXRA—thyroid cancer	2.14e-05	0.000244	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.13e-05	0.000243	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—thyroid cancer	2.01e-05	0.000229	CbGpPWpGaD
Trabectedin—SRC—Disease—BRAF—thyroid cancer	2e-05	0.000228	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—thyroid cancer	1.98e-05	0.000226	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRG1—thyroid cancer	1.97e-05	0.000225	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.96e-05	0.000224	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—thyroid cancer	1.93e-05	0.000221	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—thyroid cancer	1.93e-05	0.00022	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—thyroid cancer	1.9e-05	0.000217	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.84e-05	0.00021	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPARG—thyroid cancer	1.81e-05	0.000206	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.81e-05	0.000206	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.79e-05	0.000204	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—thyroid cancer	1.77e-05	0.000202	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—thyroid cancer	1.71e-05	0.000195	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—thyroid cancer	1.71e-05	0.000195	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIF1A—thyroid cancer	1.69e-05	0.000193	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.68e-05	0.000191	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—thyroid cancer	1.68e-05	0.000191	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RXRA—thyroid cancer	1.65e-05	0.000188	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—thyroid cancer	1.64e-05	0.000187	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—thyroid cancer	1.61e-05	0.000184	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.6e-05	0.000183	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TPR—thyroid cancer	1.58e-05	0.00018	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.55e-05	0.000177	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—thyroid cancer	1.52e-05	0.000174	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RXRA—thyroid cancer	1.52e-05	0.000173	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—thyroid cancer	1.51e-05	0.000172	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RXRA—thyroid cancer	1.5e-05	0.000172	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.46e-05	0.000167	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—thyroid cancer	1.45e-05	0.000165	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—thyroid cancer	1.42e-05	0.000162	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—thyroid cancer	1.41e-05	0.000161	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BRAF—thyroid cancer	1.4e-05	0.00016	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—thyroid cancer	1.36e-05	0.000155	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARG—thyroid cancer	1.35e-05	0.000154	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—thyroid cancer	1.26e-05	0.000143	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—thyroid cancer	1.24e-05	0.000141	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.18e-05	0.000135	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—thyroid cancer	1.17e-05	0.000134	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—thyroid cancer	1.08e-05	0.000123	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.000121	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARG—thyroid cancer	1.04e-05	0.000119	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—thyroid cancer	1.02e-05	0.000117	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—thyroid cancer	9.95e-06	0.000114	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RXRA—thyroid cancer	9.92e-06	0.000113	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—thyroid cancer	9.86e-06	0.000112	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARG—thyroid cancer	9.58e-06	0.000109	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARG—thyroid cancer	9.5e-06	0.000108	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—thyroid cancer	9.26e-06	0.000106	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—thyroid cancer	9.19e-06	0.000105	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—thyroid cancer	8.79e-06	0.0001	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—thyroid cancer	8.79e-06	0.0001	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—thyroid cancer	8.19e-06	9.35e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—thyroid cancer	8.11e-06	9.26e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—thyroid cancer	7.57e-06	8.64e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.54e-06	8.6e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—thyroid cancer	7.47e-06	8.52e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—thyroid cancer	7.14e-06	8.15e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—thyroid cancer	7.14e-06	8.15e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—thyroid cancer	6.73e-06	7.68e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—thyroid cancer	6.57e-06	7.5e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—thyroid cancer	6.51e-06	7.43e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—thyroid cancer	6.43e-06	7.34e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARG—thyroid cancer	6.26e-06	7.15e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—thyroid cancer	5.68e-06	6.48e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—thyroid cancer	5.34e-06	6.09e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.93e-06	5.62e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—thyroid cancer	4.3e-06	4.9e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—thyroid cancer	4.12e-06	4.7e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—thyroid cancer	3.79e-06	4.32e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—thyroid cancer	3.75e-06	4.28e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—thyroid cancer	2.48e-06	2.83e-05	CbGpPWpGaD
